<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03394131</url>
  </required_header>
  <id_info>
    <org_study_id>Rheumatoid arthritis CT</org_study_id>
    <nct_id>NCT03394131</nct_id>
  </id_info>
  <brief_title>Hydro-dissection of Median Nerve in Rheumatoid Arthritis Patients</brief_title>
  <official_title>Treatment of Carpal Tunnel in Rheumatoid Arthritis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Carpal tunnel syndrome (CTS) is a common peripheral entrapment neuropathy in Rheumatoid
      arthritis patients proved by nerve conduction studies and ultrasound parameters, this study
      aims to evaluate the effect of hydro-dissection using 1% lidocain followed by low molecular
      weight Sodium hyaluronate versus 40 mg of triamcinolone acetonide, ultrasounic guided.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Carpal tunnel syndrome (CTS) is a common peripheral entrapment neuropathy in Rheumatoid
      arthritis patients proved by nerve conduction studies and ultrasound parameters, this study
      aims to evaluate the effect of hydro-dissection of median nerve inside the carpal tunnel
      using 1% lidocain followed by low molecular weight Sodium hyaluronate versus 40 mg of
      triamcinolone acetonide, ultrasounic guided.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 1, 2017</start_date>
  <completion_date type="Anticipated">April 1, 2018</completion_date>
  <primary_completion_date type="Anticipated">March 1, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>pain</measure>
    <time_frame>1 year</time_frame>
    <description>using VAS</description>
  </primary_outcome>
  <primary_outcome>
    <measure>patient satesfaction</measure>
    <time_frame>1 year</time_frame>
    <description>Likert scale</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>nerve conduction</measure>
    <time_frame>1 year</time_frame>
    <description>sensory velocity</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Treatment Resistant Carpal Tunnel in RA Patients</condition>
  <arm_group>
    <arm_group_label>Hyaluronic</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>hydro-dissection using 1% lidocain followed by low molecular weight Sodium hyaluronate</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>hydro-dissection using 1% lidocain followed by saline injection</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Hyalgan Injectable Product</intervention_name>
    <description>hydro-dissection injection of median nerve inside carpal tunnel using 1% lidocain followed by Sodium hyaluronate</description>
    <arm_group_label>Hyaluronic</arm_group_label>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>hyalgan</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Rheumatoid arthritis in remission

        Exclusion Criteria:

          -  active Rheumatoid arthritis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Manal Hassanien, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assiut University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Manal Hassanien, MD</last_name>
    <phone>01062679200</phone>
    <email>manal_hassanien@yahoo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Abdelraheem Elawamy, MD</last_name>
    <phone>01000032655</phone>
    <email>arawamyyy@yahoo.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Manal Hassanien</name>
      <address>
        <city>Assiut</city>
        <state>Assuit</state>
        <zip>71111</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Manal Hassanien, MD</last_name>
      <phone>01062679200</phone>
      <email>manal_hassanien@yahoo.com</email>
    </contact>
    <contact_backup>
      <last_name>Abdelraheem Elawamy, MD</last_name>
      <phone>01000032655</phone>
      <email>arawamyyy@yahoo.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 25, 2017</study_first_submitted>
  <study_first_submitted_qc>January 3, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">January 9, 2018</study_first_posted>
  <last_update_submitted>January 3, 2018</last_update_submitted>
  <last_update_submitted_qc>January 3, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 9, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Manal Hassanien</investigator_full_name>
    <investigator_title>principle investigaror</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arthritis, Rheumatoid</mesh_term>
    <mesh_term>Carpal Tunnel Syndrome</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
    <mesh_term>Hyaluronic Acid</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>after complete recruiting of patients</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

